Marketing-authorisation holder · Serbia
Zentiva Pharma D.o.o.
210 medicines in 1 country, as authorisation holder.
Loading your page…
Marketing-authorisation holder · Serbia
210 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 210
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Abirateron Zentiva®500mg · film tableta | Abiraterone | Serbia | Authorised | 2023 |
| Abirateron Zentiva®500mg · film tableta | Abiraterone | Serbia | Authorised | 2023 |
| Abirateron Zentiva®250mg · tableta | Abiraterone | Serbia | Authorised | 2023 |
| Abirateron Zentiva®250mg · tableta | Abiraterone | Serbia | Authorised | 2023 |
| Alpha D3®0.5mcg · kapsula, meka | Alfacalcidol | Serbia | Authorised | 2023 |
| Alpha D3®0.25mcg · kapsula, meka | Alfacalcidol | Serbia | Authorised | 2024 |
| Alpha D3®1mcg · kapsula, meka | Alfacalcidol | Serbia | Authorised | 2023 |
| Alpha D3®1mcg · kapsula, meka | Alfacalcidol | Serbia | Authorised | 2023 |
| Alpha D3®0.5mcg · kapsula, meka | Alfacalcidol | Serbia | Authorised | 2023 |
| Alpha D3®0.25mcg · kapsula, meka | Alfacalcidol | Serbia | Authorised | 2024 |
| Alvodronic®3mg/3mL · rastvor za injekciju u napunjenom injekcionom špricu | Ibandronic acid | Serbia | Authorised | 2024 |
| Alvodronic®150mg · film tableta | Ibandronic acid | Serbia | Authorised | 2022 |
| Alvodronic®3mg/3mL · rastvor za injekciju u napunjenom injekcionom špricu | Ibandronic acid | Serbia | Authorised | 2024 |
| Alvokast®5mg · tableta za žvakanje | Montelukast | Serbia | Authorised | 2022 |
| Alvokast®10mg · film tableta | Montelukast | Serbia | Authorised | 2022 |
| Alvokast®4mg · tableta za žvakanje | Montelukast | Serbia | Authorised | 2022 |
| Alvolamid®5mg/mL · rastvor za infuziju | Levofloxacin | Serbia | Authorised | 2024 |
| Alvolamid®5mg/mL · rastvor za infuziju | Levofloxacin | Serbia | Authorised | 2024 |
| Alvotinib®100mg · film tableta | Imatinib | Serbia | Authorised | 2024 |
| Alvotinib®400mg · film tableta | Imatinib | Serbia | Authorised | 2024 |
| ALYMSYS®100mg/4mL · koncentrat za rastvor za infuziju | Bevacizumab | Serbia | Authorised | 2022 |
| ALYMSYS®400mg/16mL · koncentrat za rastvor za infuziju | Bevacizumab | Serbia | Authorised | 2022 |
| Ambrisentan Zentiva®5mg · film tableta | Ambrisentan | Serbia | Authorised | 2024 |
| Ambrisentan Zentiva®5mg · film tableta | Ambrisentan | Serbia | Authorised | 2024 |
| Ambrisentan Zentiva®10mg · film tableta | Ambrisentan | Serbia | Authorised | 2024 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Serbia | 210 | 210 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.